Introduction: Tumor markers as clinical cancer tests - Are we there yet?

Seminars in Oncology

Volumn 29, Issue 3, 2002, Pages 211-212

  Schilsky, Richard L ^a   Taube, Sheila E ^b  

^a UNIVERSITY OF CHICAGO   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; CA 125 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; CHORIONIC GONADOTROPIN; PROSTATE SPECIFIC ANTIGEN; TUMOR MARKER;

CANCER RESEARCH; CANCER SCREENING; CLINICAL EXAMINATION; CLINICAL LABORATORY; DISEASE MARKER; EDITORIAL; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; ARTICLE; METABOLISM; NEOPLASM; ONCOLOGY;

HUMANS; MEDICAL ONCOLOGY; NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 0036272495     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: 10.1053/sonc.2002.32890     Document Type: Article

References (0)